Bod Australia receives early green light to commence cannabis clinical trial
The trial which will determine the safety, tolerability and pharmacokinetics of its proprietary 'ECs315' CBD extract, with the extracts being administered as a single or multiple sublingual wafer and oil to 24 healthy volunteers. Bod Australia said the trial is now expected to commence in the “near-term and …